Home/Filings/4/0001437749-25-035654
4//SEC Filing

Gregoire Sylvie 4

Accession 0001437749-25-035654

CIK 0001053691other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 7:45 AM ET

Size

7.7 KB

Accession

0001437749-25-035654

Insider Transaction Report

Form 4
Period: 2025-11-17
Gregoire Sylvie
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2025-11-17$8.46/sh+10,807$91,42712,500 total(indirect: By Spouse)
  • Purchase

    Common Stock

    2025-11-17$8.46/sh+10,793$91,3091,484,078 total
Footnotes (5)
  • [F1]Shares purchased in open-market transactions.
  • [F2]The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.38 to $8.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.
  • [F3]Includes (i) 1,471,578 hares held jointly by the Reporting Person and her spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors and (ii) 12,500 shares held by the Sylvie Gregoire Roth IRA.
  • [F4]Shares held by the John J. Alam Roth IRA.
  • [F5]The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.39 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.

Issuer

CervoMed Inc.

CIK 0001053691

Entity typeother

Related Parties

1
  • filerCIK 0001335822

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 7:45 AM ET
Size
7.7 KB